James C. Czirr, Director, 10% Owner at GALECTIN THERAPEUTICS INC (GALT), sold 10,000 shares at $2.09 ($21K) on 2022-07-22, disclosed to the SEC on 2022-08-09.
Scheduled sale ($21k) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-05-04 | $109K | — | Filing → |
| GALT | SELL | 2021-04-05 | $22K | — | Filing → |